In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation

Sekhar Dharmarajan, Makio Hayama, James Kozlowski, Takaaki Ishiyama, Mikio Okazaki, Phillip Factor, G. Alexander Patterson, Daniel P. Schuster

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Experimental gene therapy is a promising strategy to prevent ischemia-reperfusion (I/R) injury and allograft rejection after lung transplantation, and methods will eventually be needed to characterize pulmonary transgene expression in vivo in humans. Therefore, we studied positron emission tomography (PET) as a means of performing in vivo molecular imaging in rodent models of lung transplantation. Rats were transfected endotracheally with adenovirus encoding a fusion gene of a mutant Herpes simplex virus-1 thymidine kinase and the green fluorescent protein gene (the former serving as an imaging reporter gene). Twenty-four hours after transfection, lungs were transplanted in groups representing normal transplantation, I/R injury and acute allograft rejection. Imaging was obtained either 24 h after transplantation to study reperfusion injury or 4 days after transplantation to study graft rejection. After imaging, lungs were excised and analyzed for thymidine kinase activity. Imaging detected transgene expression in transplanted lungs even in the presence of acute rejection or I/R injury. The PET imaging signal correlated with in vitro lung tissue assays of thymidine kinase activity (r2 = 0.534). Thus, noninvasive molecular imaging with PET is a feasible, sensitive and quantitative method for characterizing pulmonary transgene expression in experimental lung transplantation.

Original languageEnglish
Pages (from-to)1216-1225
Number of pages10
JournalAmerican Journal of Transplantation
Volume5
Issue number6
DOIs
Publication statusPublished - Jun 1 2005
Externally publishedYes

Fingerprint

Molecular Imaging
Lung Transplantation
Reperfusion Injury
Gene Expression
Lung
Thymidine Kinase
Transgenes
Positron-Emission Tomography
Transplantation
Allografts
Investigational Therapies
Gene Fusion
Graft Rejection
Human Herpesvirus 1
Green Fluorescent Proteins
Reporter Genes
Adenoviridae
Genetic Therapy
Transfection
Rodentia

Keywords

  • Gene therapy
  • Lung transplantation
  • Molecular imaging

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation. / Dharmarajan, Sekhar; Hayama, Makio; Kozlowski, James; Ishiyama, Takaaki; Okazaki, Mikio; Factor, Phillip; Patterson, G. Alexander; Schuster, Daniel P.

In: American Journal of Transplantation, Vol. 5, No. 6, 01.06.2005, p. 1216-1225.

Research output: Contribution to journalArticle

Dharmarajan, S, Hayama, M, Kozlowski, J, Ishiyama, T, Okazaki, M, Factor, P, Patterson, GA & Schuster, DP 2005, 'In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation', American Journal of Transplantation, vol. 5, no. 6, pp. 1216-1225. https://doi.org/10.1111/j.1600-6143.2005.00847.x
Dharmarajan, Sekhar ; Hayama, Makio ; Kozlowski, James ; Ishiyama, Takaaki ; Okazaki, Mikio ; Factor, Phillip ; Patterson, G. Alexander ; Schuster, Daniel P. / In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation. In: American Journal of Transplantation. 2005 ; Vol. 5, No. 6. pp. 1216-1225.
@article{e0e8f9068f364486bfbddeb668f7c2d8,
title = "In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation",
abstract = "Experimental gene therapy is a promising strategy to prevent ischemia-reperfusion (I/R) injury and allograft rejection after lung transplantation, and methods will eventually be needed to characterize pulmonary transgene expression in vivo in humans. Therefore, we studied positron emission tomography (PET) as a means of performing in vivo molecular imaging in rodent models of lung transplantation. Rats were transfected endotracheally with adenovirus encoding a fusion gene of a mutant Herpes simplex virus-1 thymidine kinase and the green fluorescent protein gene (the former serving as an imaging reporter gene). Twenty-four hours after transfection, lungs were transplanted in groups representing normal transplantation, I/R injury and acute allograft rejection. Imaging was obtained either 24 h after transplantation to study reperfusion injury or 4 days after transplantation to study graft rejection. After imaging, lungs were excised and analyzed for thymidine kinase activity. Imaging detected transgene expression in transplanted lungs even in the presence of acute rejection or I/R injury. The PET imaging signal correlated with in vitro lung tissue assays of thymidine kinase activity (r2 = 0.534). Thus, noninvasive molecular imaging with PET is a feasible, sensitive and quantitative method for characterizing pulmonary transgene expression in experimental lung transplantation.",
keywords = "Gene therapy, Lung transplantation, Molecular imaging",
author = "Sekhar Dharmarajan and Makio Hayama and James Kozlowski and Takaaki Ishiyama and Mikio Okazaki and Phillip Factor and Patterson, {G. Alexander} and Schuster, {Daniel P.}",
year = "2005",
month = "6",
day = "1",
doi = "10.1111/j.1600-6143.2005.00847.x",
language = "English",
volume = "5",
pages = "1216--1225",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation

AU - Dharmarajan, Sekhar

AU - Hayama, Makio

AU - Kozlowski, James

AU - Ishiyama, Takaaki

AU - Okazaki, Mikio

AU - Factor, Phillip

AU - Patterson, G. Alexander

AU - Schuster, Daniel P.

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Experimental gene therapy is a promising strategy to prevent ischemia-reperfusion (I/R) injury and allograft rejection after lung transplantation, and methods will eventually be needed to characterize pulmonary transgene expression in vivo in humans. Therefore, we studied positron emission tomography (PET) as a means of performing in vivo molecular imaging in rodent models of lung transplantation. Rats were transfected endotracheally with adenovirus encoding a fusion gene of a mutant Herpes simplex virus-1 thymidine kinase and the green fluorescent protein gene (the former serving as an imaging reporter gene). Twenty-four hours after transfection, lungs were transplanted in groups representing normal transplantation, I/R injury and acute allograft rejection. Imaging was obtained either 24 h after transplantation to study reperfusion injury or 4 days after transplantation to study graft rejection. After imaging, lungs were excised and analyzed for thymidine kinase activity. Imaging detected transgene expression in transplanted lungs even in the presence of acute rejection or I/R injury. The PET imaging signal correlated with in vitro lung tissue assays of thymidine kinase activity (r2 = 0.534). Thus, noninvasive molecular imaging with PET is a feasible, sensitive and quantitative method for characterizing pulmonary transgene expression in experimental lung transplantation.

AB - Experimental gene therapy is a promising strategy to prevent ischemia-reperfusion (I/R) injury and allograft rejection after lung transplantation, and methods will eventually be needed to characterize pulmonary transgene expression in vivo in humans. Therefore, we studied positron emission tomography (PET) as a means of performing in vivo molecular imaging in rodent models of lung transplantation. Rats were transfected endotracheally with adenovirus encoding a fusion gene of a mutant Herpes simplex virus-1 thymidine kinase and the green fluorescent protein gene (the former serving as an imaging reporter gene). Twenty-four hours after transfection, lungs were transplanted in groups representing normal transplantation, I/R injury and acute allograft rejection. Imaging was obtained either 24 h after transplantation to study reperfusion injury or 4 days after transplantation to study graft rejection. After imaging, lungs were excised and analyzed for thymidine kinase activity. Imaging detected transgene expression in transplanted lungs even in the presence of acute rejection or I/R injury. The PET imaging signal correlated with in vitro lung tissue assays of thymidine kinase activity (r2 = 0.534). Thus, noninvasive molecular imaging with PET is a feasible, sensitive and quantitative method for characterizing pulmonary transgene expression in experimental lung transplantation.

KW - Gene therapy

KW - Lung transplantation

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=20544461367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20544461367&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2005.00847.x

DO - 10.1111/j.1600-6143.2005.00847.x

M3 - Article

VL - 5

SP - 1216

EP - 1225

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 6

ER -